MAPT and neurodegenerative disease: To date, studies of glymphatic clearance mechanisms in neurodegenerative diseases have largely focused on amyloid-β, but more recent studies showed that proteins prone to intracellular accumulation can also be subject to glymphatic clearance—as discussed above, in the case of tau.